← Leaderboards
Zandrea Ambrose
University Of Pittsburgh At Pittsburgh
$12,803,889
Attributed
$17,722,826
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,722,826 · 10
By mechanism
R01$11,475,421 · 4
U54$3,390,079 · 2
P50$1,994,038 · 2
R21$863,288 · 2
Top collaborators
- Philana Ling Lin5 shared
- Pleuni Pennings5 shared
- Suryaram Gummuluru3 shared
- Bjoern Markus Reinhard3 shared
- Haitao Guo2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Nicolas P Sluis-Cremer$13,171,852
- John W Mellors$70,850,753
- Pleuni Pennings$1,606,823
- Philana Ling Lin$10,232,778
- Eric S Goetzman$9,365,754
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionHiv-1VirusAnti-Retroviral AgentsTissuesViralVirus ReplicationAntiretroviral TherapySiteMutationMacacaHigh RiskMediatingBindingMacrophagePharmaceutical PreparationsVaccinesComplexSpatiotemporalBloodIn VivoImageProteins
Grant awards (31)
Improved Nanoparticle Targeting of Tissue Myeloid Cells for HIV-1 Long-acting Pre-exposure Prophylaxis$657,525
R01 · FY2025 · AI
Project 2. Immune evasion, trafficking, and nuclear import$560,570
U54 · FY2025 · AI · contact PI
Project 2. Immune evasion, trafficking, and nuclear import$804,493
U54 · FY2024 · AI · contact PI
Improved Nanoparticle Targeting of Tissue Myeloid Cells for HIV-1 Long-acting Pre-exposure Prophylaxis$788,992
R01 · FY2024 · AI
Project 2. Immune evasion, trafficking, and nuclear import$420,855
U54 · FY2024 · AI · contact PI
Live-cell imaging of SARS-CoV-2 replication organelle formation and RNA synthesis$235,550
R21 · FY2024 · AI · contact PI
Project 2. Immune evasion, trafficking, and nuclear import$862,186
U54 · FY2023 · AI · contact PI
Improved Nanoparticle Targeting of Tissue Myeloid Cells for HIV-1 Long-acting Pre-exposure Prophylaxis$787,467
R01 · FY2023 · AI
Live-cell imaging of SARS-CoV-2 replication organelle formation and RNA synthesis$195,800
R21 · FY2023 · AI · contact PI
Project 2. Immune evasion, trafficking, and nuclear import$741,975
U54 · FY2022 · AI · contact PI
Pathogenesis of HIV and HBV Co-Infection in a Humanized Mouse Model$236,313
R21 · FY2022 · OD · contact PI
Influence of SIV replication on TB progression and immunity$945,816
R01 · FY2021 · AI · contact PI
Project 4: Capsid and nuclear import/integration co-factors$301,972
P50 · FY2021 · AI · contact PI
Pathogenesis of HIV and HBV Co-Infection in a Humanized Mouse Model$195,625
R21 · FY2021 · OD · contact PI
Influence of SIV replication on TB progression and immunity$1,023,452
R01 · FY2020 · AI · contact PI
Project 4: Capsid and nuclear import/integration co-factors$413,270
P50 · FY2020 · AI · contact PI
Influence of SIV replication on TB progression and immunity$1,029,305
R01 · FY2019 · AI · contact PI
Visualization of in vivo HIV-1 vaginal transmission in the presence and absence of PrEP$553,221
R01 · FY2019 · AI · contact PI
Project 4: Capsid and nuclear import/integration co-factors$411,675
P50 · FY2019 · AI · contact PI
Influence of SIV replication on TB progression and immunity$933,104
R01 · FY2018 · AI · contact PI
Visualization of in vivo HIV-1 vaginal transmission in the presence and absence of PrEP$553,221
R01 · FY2018 · AI · contact PI
Project 4: Capsid and nuclear import/integration co-factors$431,675
P50 · FY2018 · GM · contact PI
Influence of SIV replication on TB progression and immunity$888,791
R01 · FY2017 · AI · contact PI
Visualization of in vivo HIV-1 vaginal transmission in the presence and absence of PrEP$553,221
R01 · FY2017 · AI · contact PI
Project 4: Capsid and nuclear import/integration co-factors$435,446
P50 · FY2017 · GM · contact PI
Visualization of in vivo HIV-1 vaginal transmission in the presence and absence of PrEP$613,909
R01 · FY2016 · AI · contact PI
Visualization of in vivo HIV-1 vaginal transmission in the presence and absence of PrEP$658,165
R01 · FY2015 · AI · contact PI
Origin and Evolution of HIV-1 Drug Resistance in the RT-SHIVmne Macaque Model$168,932
R01 · FY2013 · AI · contact PI
Origin and Evolution of HIV-1 Drug Resistance in the RT-SHIVmne Macaque Model$213,679
R01 · FY2012 · AI · contact PI
Origin and Evolution of HIV-1 Drug Resistance in the RT-SHIVmne Macaque Model$328,517
R01 · FY2011 · AI · contact PI
Origin and Evolution of HIV-1 Drug Resistance in the RT-SHIVmne Macaque Model$778,104
R01 · FY2010 · AI · contact PI